The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents.
Lloyd GK, Menzaghi F, Bontempi B, Suto C, Siegel R, Akong M, Stauderman K, Velicelebi G, Johnson E, Harpold MM, Rao TS, Sacaan AI, Chavez-Noriega LE, Washburn MS, Vernier JM, Cosford ND, McDonald LA.
Lloyd GK, et al. Among authors: vernier jm.
Life Sci. 1998;62(17-18):1601-6. doi: 10.1016/s0024-3205(98)00114-3.
Life Sci. 1998.
PMID: 9585143
Review.